0HD2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Alnylam Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 266.09 USD 0.7% Market Closed

Market Cap: $35.2B

	Alnylam Pharmaceuticals Inc LSE:0HD2	US
	Secom Co Ltd TSE:9735	JP
	Repay Holdings Corp F:0YR	US
F	Fluent Inc F:7TM	US
T	Thai Airways International PCL SET:THAI	TH
G	GomSpace Group AB STO:GOMX	SE
R	Roper Technologies Inc F:ROP	US
B	Banco Santander Brasil SA BOVESPA:SANB3	BR
	Iovance Biotherapeutics Inc NASDAQ:IOVA	US
M	MSA Safety Inc F:M07	US
	Arrow Electronics Inc NYSE:ARW	US
	New China Life Insurance Co Ltd F:NCL	CN

Profitability Summary

Alnylam Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

84%

Declining Gross Margin

81% > 80%

Healthy Operating Margin

20%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-73% > 20%

Healthy Net Margin

17%

Negative 3Y Average Net Margin

-7%

Net Margin is Increasing

-86% > 17%

Exceptional Free Cash Flow Margin

17%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-44% > 17%

Exceptional ROE

101%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.